Cardio-metabolic risk factors at the baseline according to use of statins in a high-risk cohort of the FIN-D2D
| Variable | Use of statins | ||||
|---|---|---|---|---|---|
| User | Non-user | ||||
| N | Mean (SD) | N | Mean (SD) | p Value | |
| Age (years) | 484 | 59.0 (8.59) | 2314 | 53.7 (10.6) | <0.001 |
| Weight (kg) | 484 | 87.2 (14.9) | 2314 | 87.8 (16.9) | 0.442 |
| BMI (kg/m2) | 484 | 31.0 (4.58) | 2302 | 31.5 (5.30) | 0.027 |
| Systolic BP (mm Hg) | 472 | 140 (16.5) | 2276 | 139 (17.5) | 0.166 |
| Diastolic BP (mm Hg) | 472 | 85 (9.00) | 2276 | 86 (9.45) | 0.002 |
| Total cholesterol (mmol/l) | 429 | 4.78 (0.99) | 2051 | 5.26 (0.95) | <0.001 |
| HDL cholesterol (mmol/l) | 425 | 1.38 (0.37) | 2028 | 1.43 (0.43) | 0.019* |
| LDL cholesterol (mmol/l) | 415 | 2.65 (0.87) | 1979 | 3.14 (0.84) | <0.001 |
| Triglycerides (mmol/l) | 424 | 1.68 (0.90) | 2019 | 1.56 (0.95) | 0.001* |
| Fasting glucose (mmol/l) | 424 | 5.84 (0.55) | 2008 | 5.77 (0.58) | 0.016 |
| 2 h glucose (mmol/l) | 421 | 7.11 (1.81) | 1999 | 6.91 (1.82) | 0.046 |
p Values for independent sample t test.
*Log-transformed triglyceride values are used in the statistical test.
BP, blood pressure; BMI, body mass index; FIN-D2D, Implementation project of the national diabetes prevention programme in Finland; HDL, high-density lipoprotein; LDL, low-density lipoprotein.